COVID-19患者插管后纵隔气肿:病例系列
2020年3-4月COVID-19疫情期间,插管患者增多,胸外科发现插管后重度纵隔气肿需外科会诊的病例增加。本文报告7天内5例需减压治疗的重度纵隔气肿患者,推测机制为疾病病理生理导致肺泡损伤和气管支气管损伤风险增加,加上使用大口径气管导管和较高通气压力。
要点
- COVID-19插管患者可能出现重度纵隔气肿,需警惕并早期识别。
- 机制可能涉及肺泡损伤、气管支气管损伤、大口径导管和高通气压力。
- 需减压治疗的重度纵隔气肿是可危及生命的并发症,应提供管理指导。
核心结论
- COVID-19插管患者中重度纵隔气肿发生率增加,需警惕这一潜在危及生命的并发症。
研究设计与样本
- 病例系列,报告7天内5例需减压治疗的重度纵隔气肿患者。
主要发现
- 胸外科在COVID-19插管患者中见到需外科会诊的重度纵隔气肿增加。
- 7天内出现5例需减压治疗的重度纵隔气肿。
临床怎么用
- 对COVID-19插管患者应警惕纵隔气肿,并提供管理指导给重症监护医生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The number of patients requiring tracheal intubation rose dramatically in March and April 2020 with the COVID-19 outbreak. Our thoracic surgery department has seen an increased incidence of severe pneumomediastinum referred for surgical opinion in intubated patients with COVID-19 pneumonitis. Here we present a series of five patients with severe pneumomediastinum requiring decompression therapy over a 7-day period in the current COVID-19 outbreak. We hypothesise that the mechanism for this is the aggressive disease pathophysiology with an increased risk of alveolar damage and tracheobronchial injury, along with the use of larger-bore tracheal tubes and higher ventilation pressures. We present this case series in order to highlight the increased risk of this potentially life-threatening complication among the COVID-19 patient cohort and offer guidance for its management to critical care physicians.
引用
- Wali A, Rizzo V, Bille A, et al. Pneumomediastinum following intubation in COVID-19 patients: a case series. Anaesthesia. 2020. PMID: 32375200. doi:10.1111/anae.15113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。